Structure-Based Design Strategies for Coumarin-Derived CDK4 Inhibitors in Non-Small Cell Lung Cancer: Current Progress and Therapeutic Perspectives
Current evidence suggests that enhanced CDK4 selectivity and rational combination strategies may improve the therapeutic index in NSCLC and coumarin-based scaffolds are promising platforms for CDK4-targeted drug development.